JCAD | The Journal of Clinical and Aesthetic Dermatology (JCAD)

JCAD | The Journal of Clinical and Aesthetic Dermatology

   

JCAD » 2009 » April

Archives

Sponsors

<img src="http://www.jcadonline.com/ad-content/cloderm/banner_noflash.png" >

Long-term Management of Actinic Keratosis: Proceedings from a Clinical Dermatology Roundtable

April 2009

This supplement is based on a roundtable discussion that took place on October 16, 2008 during the 2008 Fall Clinical Dermatology Conference in Las Vegas, Nevada. Dr. Del Rosso moderated the discussion. Roundtable participants included Drs. Ceilley, Kaufmann, Lebwohl, and Torres, with additional commentary by Dr. Pariser. This supplement was supported by PharmaDerm, a division of Nycomed US Inc

Read the rest of this article »

Posted in Supplements | No Comments »

Safety and Efficacy of Multiple 16-week Courses of Topical Imiquimod for the Treatment of Large Areas of Skin Involved with Actinic Keratoses

April 2009

James Q. Del Rosso, DO, FAOCD; Valley Hospital Medical Center, Las Vegas, Nevada

Howard Sofen, MD; Dermatology Associates, Los Angeles, California;

Barry Leshin, MD; The Skin Surgery Center, Winston-Salem, North Carolina

TC Meng, MD; James Kulp, BS and Sharon Levy, MD, Graceway Pharmaceuticals, Bristol, Tennessee Read the rest of this article »

Posted in 04-2009 (April 2009), Actinic Keratoses, Original Research | No Comments »

Is There a Potential Role for Anti-tumor Necrosis Factor Therapy in Patients with Human Immunodeficiency Virus?

April 2009

Jason J. Emer, MD; The Mount Sinai School of Medicine, Department of Dermatology, New York, New York Read the rest of this article »

Posted in 04-2009 (April 2009), Anti-tumor Necrosis Factor, Literature Review | No Comments »

Reduction in Procedure-associated Pain by Treatment with a Unique Topical Anesthetic Foam Containing 4% Lidocaine

April 2009

Ellen Frankel, MD,St. Joseph’s Hospital, Providence, Rhode Island

Mark W. Trumbore, PhD, Collegium Pharmaceutical, Cumberland, Rhode Island

Disclosure: Dr. Frankel has received research support from Onset Therapeutics. Dr. Trumbore is employed by Collegium Pharmaceutical. Read the rest of this article »

Posted in 04-2009 (April 2009), Original Research | No Comments »

Self-diagnosis of Mild-to-Moderate Acne for Self Treatment with Blue Light Therapy

April 2009

Michael H. Gold, MD, Tennessee Clinical Research Center, Nashville, Tennessee;

Anneke Andriessen; RBC Consultants, The Netherlands

Julie Biron, Tennessee Clinical Research Center, Nashville, Tennessee;

Disclosure: Dr. Gold is a consultant to, performs research for, speaks for, and receives honoraria from Pharos Life; Ms. Andriessen and Ms. Biron report no relevant conflicts of interest. Read the rest of this article »

Posted in 04-2009 (April 2009), Blue Light Therapy, General, Original Research | No Comments »

Use of Oral Doxycycline for Community-acquired Methicillin-resistant Staphylococcus aureus (CA-MRSA) Infections

April 2009

James Q. Del Rosso, DO, FAOCD;
Sanjay Bhambri, DO;
Grace Kim, DO

Dr. Del Rosso is Dermatology Residency Director, Valley Hospital Medical Center, Las Vegas, Nevada, Touro University College of Osteopathic Medicine, Henderson, Nevada; Clinical Associate Professor, Dermatology, University of Nevada School of Medicine, Las Vegas, Nevada; Las Vegas Skin & Cancer Clinics, Las Vegas and Henderson, Nevada. Dr. Bhambri is Chief Dermatology Resident, Valley Hospital Medical Center, Las Vegas, Nevada. Dr. Kim is a dermatologist at Valley Hospital Medical Center, Las Vegas, Nevada. The authors report no conflicts of interest in relationship to the content of this article. Read the rest of this article »

Posted in 04-2009 (April 2009), Doxycycline Therapy, Questions-Challenges-Controversies | No Comments »